Continuous Blood Glucose Monitoring Market 2030 Report: Tracking Trends and Growth Status
Global Continuous Blood Glucose Monitoring Market Size Was Valued At USD 5.90 Billion In 2022 And Is Projected To Reach USD 13.28 Billion By 2030, Growing At A CAGR Of 12.3% From 2022 To 2030.
The manufacturing, marketing, and use of medical devices intended to continuously monitor blood glucose levels in diabetics are all included in the Continuous Blood Glucose Monitoring (CGM) Market. Sensors that measure interstitial fluid glucose levels, transmitters that deliver data to receivers or cellphones, and display devices or applications for real-time glucose monitoring make up CGM systems. These devices offer insightful information on glucose patterns to both diabetics and medical experts, enabling proactive diabetes treatment and lowering the risk of hyper- or hypoglycemia. Patient adherence, data integration capabilities, sensor accuracy, and convenience of use are important factors in the industry. Market dynamics are impacted by a number of variables, including the rising incidence of diabetes, developments in sensor technology, and reimbursement regulations.
Top Key Players Covered in The Continuous Blood Glucose Monitoring Market
Abbott (U.S.), ACON Laboratories (US), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), B. Braun Melsungen AG (Germany), Beta Bionics, Inc. (US), Dexcom, Inc. (U.S.), Echo Therapeutics Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlySens Incorporated (US), Integrity Applications Inc., LifeScan IP Holdings, LLC (U.S.), Medisana AG (Germany), Medtronic (Ireland), Metronom Health Inc. (US), Nipro (Japan), Nova Biomedical (US), OrSense Ltd. (Israel), PKvitality (France), Prodigy Diabetes Care (US), Sanofi (France), Senseonics (U.S.), Siren Care, Inc. (US), Terumo Corporation (Japan), Ypsomed (Switzerland), and other major players.
Begin Your Analysis with a Free Sample Report!
Introspective Market Research specializes in delivering comprehensive market research studies that provide valuable insights and strategic guidance to businesses worldwide. Our reports draw data from diverse and solid primary and secondary sources. By utilizing industry-standard tools like Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, we enhance the comprehensiveness of our evaluations.
In addition to investigating market intricacies, our study focuses extensively on the holistic ecosystem of the keyword market. We analyse the functions and interdependencies of diverse market stakeholders, offering insights into their roles within the industry. Furthermore, our wide-ranging geographical coverage facilitates a profound understanding of regional trends.
Discount on the Research Report@
Segmentation Analysis of the Continuous Blood Glucose Monitoring Market
Continuous Blood Glucose Monitoring market segments cover the Product, application, and end-users. By Product, the Sensors segment is anticipated to dominate the Market over the Forecast period.
By Product
Receivers
Sensors
Insulin Pump
By Testing Site
Fingertip testing
Alternate Site Testing
By End-User
Home Care
Diagnostics Centres
Hospitals
Customization Options Available - Contact Us!
The Continuous Blood Glucose Monitoring Market Trend Analysis
Rising Prevalence of Diabetes to Surge the Demand for Blood Glucose Monitoring
Fast urbanization and the growing tendency of sedentary lifestyles in both developed and developing countries are the main causes of the rising incidence of diabetes. For example, the International Diabetes Federation reported that 537 million adults globally had diabetes in 2021, with an estimated 51.6% of those people living in China, India, the United States, Brazil, and Mexico. Worldwide adoption of these systems has accelerated due to the large rise in the number of persons with type 1 or insulin-dependent type 2 diabetes.
Increased Diabetes Prevalence
The rising incidence of diabetes worldwide offers makers of continuous glucose monitors (CGMs) a substantial and long-term opportunity. A number of variables, such as aging populations, sedentary lifestyles, and poor eating habits, are coming together to drive this trend. Because diabetes is more common in the elderly, its frequency increases as the world's population ages. This change in the population generates a constant need for reliable glucose monitoring devices.
By Region
North America (US, Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
South America (Brazil, Argentin
Global Continuous Blood Glucose Monitoring Market Size Was Valued At USD 5.90 Billion In 2022 And Is Projected To Reach USD 13.28 Billion By 2030, Growing At A CAGR Of 12.3% From 2022 To 2030.
The manufacturing, marketing, and use of medical devices intended to continuously monitor blood glucose levels in diabetics are all included in the Continuous Blood Glucose Monitoring (CGM) Market. Sensors that measure interstitial fluid glucose levels, transmitters that deliver data to receivers or cellphones, and display devices or applications for real-time glucose monitoring make up CGM systems. These devices offer insightful information on glucose patterns to both diabetics and medical experts, enabling proactive diabetes treatment and lowering the risk of hyper- or hypoglycemia. Patient adherence, data integration capabilities, sensor accuracy, and convenience of use are important factors in the industry. Market dynamics are impacted by a number of variables, including the rising incidence of diabetes, developments in sensor technology, and reimbursement regulations.
Top Key Players Covered in The Continuous Blood Glucose Monitoring Market
Abbott (U.S.), ACON Laboratories (US), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), B. Braun Melsungen AG (Germany), Beta Bionics, Inc. (US), Dexcom, Inc. (U.S.), Echo Therapeutics Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlySens Incorporated (US), Integrity Applications Inc., LifeScan IP Holdings, LLC (U.S.), Medisana AG (Germany), Medtronic (Ireland), Metronom Health Inc. (US), Nipro (Japan), Nova Biomedical (US), OrSense Ltd. (Israel), PKvitality (France), Prodigy Diabetes Care (US), Sanofi (France), Senseonics (U.S.), Siren Care, Inc. (US), Terumo Corporation (Japan), Ypsomed (Switzerland), and other major players.
Begin Your Analysis with a Free Sample Report!
Introspective Market Research specializes in delivering comprehensive market research studies that provide valuable insights and strategic guidance to businesses worldwide. Our reports draw data from diverse and solid primary and secondary sources. By utilizing industry-standard tools like Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, we enhance the comprehensiveness of our evaluations.
In addition to investigating market intricacies, our study focuses extensively on the holistic ecosystem of the keyword market. We analyse the functions and interdependencies of diverse market stakeholders, offering insights into their roles within the industry. Furthermore, our wide-ranging geographical coverage facilitates a profound understanding of regional trends.
Discount on the Research Report@
Segmentation Analysis of the Continuous Blood Glucose Monitoring Market
Continuous Blood Glucose Monitoring market segments cover the Product, application, and end-users. By Product, the Sensors segment is anticipated to dominate the Market over the Forecast period.
By Product
Receivers
Sensors
Insulin Pump
By Testing Site
Fingertip testing
Alternate Site Testing
By End-User
Home Care
Diagnostics Centres
Hospitals
Customization Options Available - Contact Us!
The Continuous Blood Glucose Monitoring Market Trend Analysis
Rising Prevalence of Diabetes to Surge the Demand for Blood Glucose Monitoring
Fast urbanization and the growing tendency of sedentary lifestyles in both developed and developing countries are the main causes of the rising incidence of diabetes. For example, the International Diabetes Federation reported that 537 million adults globally had diabetes in 2021, with an estimated 51.6% of those people living in China, India, the United States, Brazil, and Mexico. Worldwide adoption of these systems has accelerated due to the large rise in the number of persons with type 1 or insulin-dependent type 2 diabetes.
Increased Diabetes Prevalence
The rising incidence of diabetes worldwide offers makers of continuous glucose monitors (CGMs) a substantial and long-term opportunity. A number of variables, such as aging populations, sedentary lifestyles, and poor eating habits, are coming together to drive this trend. Because diabetes is more common in the elderly, its frequency increases as the world's population ages. This change in the population generates a constant need for reliable glucose monitoring devices.
By Region
North America (US, Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
South America (Brazil, Argentin
9 months ago
